Stock listing
Hybio Pharmaceutical Co., Ltd. Class A
Selected listing: 300199 · SZSE · CNY · CN
Hybio Pharmaceutical Co., Ltd. Class A (Shenzhen:300199), Health Technology. Latest release Jul 6, 2026: Hybio Pharmaceutical Unit's Chemical API Liraglutide…
- Ticker
- Shenzhen:300199
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Shenzhen
- Currency
- CNY
About Hybio Pharmaceutical Co., Ltd. Class A
The company focuses on the pharmaceutical sector, contributing to the development and production of various healthcare products. Its stock is listed under the ticker symbol 300199.
Latest news from Hybio Pharmaceutical Co., Ltd. Class A
Hybio Pharmaceutical Unit's Chemical API Liraglutide Approved By China's Regulator
July 6, 2026
Hybio Pharmaceutical's Liraglutide Injection Approved By China's National Medical Products Administration
July 1, 2026
Hybio's generic weight-loss drug set for FDA review
June 30, 2026
Hybio Pharmaceutical Plans To Raise Fund Via Share Private Placement
September 25, 2025
Research Hybio Pharmaceutical Co., Ltd. Class A
Hybio Pharmaceutical Co., Ltd. Class A company profile
View the public company page for Hybio Pharmaceutical Co., Ltd. Class A on 6ix.
Hybio Pharmaceutical Co., Ltd. Class A news
Read company news and market updates connected to Hybio Pharmaceutical Co., Ltd. Class A.
Hybio Pharmaceutical Co., Ltd. Class A investor events
Find investor webinars, events, and replay context for Hybio Pharmaceutical Co., Ltd. Class A.